ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine

Journal of Chemical Information and Modeling

Volumn 47, Issue 6, 2007, Pages 2408-2415

  Hou, Tingjun ^a   Wang, Junmei ^b   Li, Youyong ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEXAS BIOTECHNOLOGY CORPORATION   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; MATHEMATICAL MODELS; MOLECULAR DYNAMICS; SUPPORT VECTOR MACHINES; WATER;

HUMAN INTESTINAL ABSORPTION (HIA); MOLECULAR DESCRIPTORS; TOPOLOGICAL POLAR SURFACE AREA (TPSA);

DRUG PRODUCTS;

DRUG;

ARTICLE; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CLASSIFICATION; DRUG DESIGN; HUMAN; INTESTINE ABSORPTION; METABOLISM;

DRUG DESIGN; HUMANS; INTESTINAL ABSORPTION; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS;

EID: 37249042636     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci7002076     Document Type: Article

References (41)

1. Kennedy, T. Managing the drug discovery/development interface. Drug Discovery Today 1997, 2, 436-444.
2. Li, A. P. Screening for human ADME/Tox drug properties in drug discovery. Drug Discovery Today 2001, 6, 357-366.
3. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997, 23, 3-25.
4. Bevan, C. D.; Lloyd, R. S. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal. Chem. 2000, 72, 1781-1787.
5. Wienkers, L. C.; Heath, T. G. Predicting in vivo drug interactions from in vitro drug discovery data. Nat. Rev. Drug Discovery 2005, 4, 825-833.
6. Crespi, C. L.; Miller, V. P.; Penman, B. W. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal. Biochem. 1997, 248, 188-190.
7. Cohen, L. H.; Remley, M. J.; Raunig, D.; Vaz, A. D. N. In vitro drug interactions of cytochrome P450: An evaluation of fluorogenic to conventional substrates. Drug Metab. Dispos. 2003, 31, 1005-1015.
8. Beresford, A. P.; Segall, M.; Tarbit, M. H. In silico prediction of ADME properties: Are we making progress? Curr. Opin. Drug Discovery 2004, 7, 36-42.
9. Hou, T. J.; Xu, X. J. Recent development and application of virtual screening in drug discovery: An overview. Curr. Pharm. Des. 2004, 10, 1011-1033.
10. Hou, T. J.; Wang, J. M.; Zhang, W.; Wang, W.; Xu, X. Recent advances in computational prediction of drug absorption and permeability in drug discovery. Curr. Med. Chem. 2006, 13, 2653-2667.
11. van de Waterbeemd, H.; Gifford, E. ADMET in silico modelling: Towards prediction paradise? Nat. Rev. Drug Discovery 2003, 2, 192-204.
12. Hou, T. J.; Wang, J. M.; Zhang, W.; Xu, X. J. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules? J. Chem. Inf. Model. 2007, 47, 460-463.
13. Hou, T. J.; Wang, J. M.; Zhang, W.; Xu, X. J. ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification. J. Chem. Inf. Model. 2007, 47, 208-218.
14. Zhao, Y. H.; Le, J.; Abraham, M. H.; Hersey, A.; Eddershaw, P. J.; Luscombe, C. N.; Boutina, D.; Beck, G.; Sherborne, B.; Cooper, I.; Platts, J. A. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. J. Pharm. Sci. 2001, 90, 749-784.
15. Wessel, M. D.; Jurs, P. C.; Tolan, J. W.; Muskal, S. M. Prediction of human intestinal absorption of drug compounds from molecular structure. J. Chem. Inf. Comput. Sci. 1998, 38, 726-735.
16. Klopman, G.; Stefan, L. R.; Saiakhov, R. D. ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans. Eur. J. Pharm. Sci. 2002, 17, 253-263.
17. Franke, L.; Byvatov, E.; Werz, O.; Steinhilber, D.; Schneider, P.; Schneider, G. Extraction and visualization of potential pharmacophore points using support vector machines: Application to ligand-based virtual screening for COX-2 inhibitors. J. Med. Chem. 2005, 48, 6997-7004.
18. Xue, Y.; Li, Z. R.; Yap, C. W.; Sun, L. Z.; Chen, X.; Chen, Y. Z. Effect of molecular descriptor feature selection in support vector machine classification of pharmacokinetic and toxicological properties of chemical agents. J. Chem. Inf. Comput. Sci. 2004, 44, 1630-1638.
19. Yap, C. W.; Chen, Y. Z. Prediction of cytochrome p450 3A4, 2D6, and 2C9 inhibitors and substrates by using support vector machines. J. Chem. Inf. Model. 2005, 45, 982-992.
20. Jorissen, R. N.; Gilson, M. K. Virtual screening of molecular databases using a Support Vector Machine. J. Chem. Inf. Model. 2005, 45, 549-561.
21. Byvatov, E.; Fechner, U.; Sadowski, J.; Schneider, G. Comparison of support vector machine and artificial neural network systems for drug/nondrug classification. J. Chem. Inf. Comput. Sci. 2003, 43, 1882-1889.
22. Warmuth, M. K.; Liao, J.; Ratsch, G.; Mathieson, M.; Putta, S.; Lemmen, C. Active learning with support vector machines in the drug discovery process. J. Chem. Inf. Comput. Sci. 2003, 43, 667-673.
23. Brown, M. P. S.; Grundy, W. N.; Lin, D.; Cristianini, N.; Sugnet, C. W.; Furey, T. S.; Ares, M.; Haussler, D. Knowledge-based analysis of microarray gene expression data by using support vector machines. Natl. Acad. Sci., U.S.A. 2000, 97, 262-267.
24. Burbidge, R.; Trotter, M.; Buxton, B.; Holden, S. Drug design by machine learning: support vector machines for pharmaceutical data analysis. Comput. Chem. 2001, 26, 5-14.
25. Plewczynski, D.; Spieser, S. A. H.; Koch, U. Assessing different classification methods for virtual screening, J. Chem. Inf. Model. 2006, 46, 1098-1106.
26. Ertl, P.; Rohde, B.; Selzer, P., Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 2000, 43, 3714-3717.
27. ACDLABS v9.0, http://www.acdlabs.com, 2005.
28. Vapnik, V.; Chapelle, O. Bounds on error expectation for support vector machines. Neural Comput. 2000, 12, 2013-2036.
29. Cortes, C.; Vapnik, V. Support-Vector Networks. Mach. Learn. 1995, 20, 273-297.
30. Scholkopf, B.; Sung, K. K.; Burges, C. J. C.; Girosi, F.; Niyogi, P.; Poggio, T.; Vapnik, V. Comparing support vector machines with Gaussian kernels to radial basis function classifiers. IEEE Trans. Signal Process. 1997, 45, 2758-2765.
31. Burges, C. J. C. A tutorial on Support Vector Machines for pattern recognition. Data Min. Knowl. Discovery 1998, 2, 121-167.
32. Chang, C. C.; Lin, C. J. LIBSVM: a library for support vector machine. Software available at http://www.csie.ntu.edu.tw/~cjlin/libsvm, 2001.
33. Vandewaterbeemd, H.; Kansy, M. Hydrogen-Bonding Capacity and Brain Penetration. Chimia 1992, 46, 299-303.
34. Palm, K.; Stenberg, P.; Luthman, K.; Artursson, P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharmaceut. Res. 1997, 14, 568-571.
35. Egan, W. J.; Merz, K. M.; Baldwin, J. J. Prediction of drug absorption using multivariate statistics. J. Med. Chem. 2000, 43, 3867-3877.
36. Hou, T. J.; Xu, X. J. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors. J. Chem. Inf. Comput. Sci. 2003, 43, 2137-2152.
37. Hou, T. J.; Zhang, W.; Xia, K.; Qiao, X. B.; Xu, X. J. ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties. J. Chem. Inf. Comput. Sci. 2004, 44, 1585-1600.
38. Linnankoski, J.; Makela, J. M.; Ranta, V. P.; Urtti, A.; Yliperttula, M. Computational prediction of oral drug absorption based on absorption rate constants in humans. J. Med. Chem. 2006, 49, 3674-3681.
39. Winiwarter, S.; Bonham, N. M.; Ax, F.; Hallberg, A.; Lennernas, H.; Karlen, A. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J. Med. Chem. 1998, 41, 4939-4949.
40. Austin, R. P.; Barton, P.; Cockroft, S. L.; Wenlock, M. C.; Riley, R. J. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab. Dispos. 2002, 30, 1497-1503.
41. Niwa, T. Using general regression and probabilistic neural networks to predict human intestinal absorption with topological descriptors derived from two-dimensional chemical structures. J. Chem. Inf. Comput. Sci. 2003, 43, 113-119.